Cumberland Pharmaceuticals Inc. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest
Cumberland Pharmaceuticals Inc. (CPIX) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest of -$8.75 thousand for the 12-month period ending 2019-12-31, per its 8-K filed 2020-12-10.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest · last filed 2020-12-10
- Cumberland Pharmaceuticals Inc. other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for fiscal 2016 was -$59.26K.
- Cumberland Pharmaceuticals Inc. other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for fiscal 2015 was -$60.24K.
- Cumberland Pharmaceuticals Inc. other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for fiscal 2014 was -$61.26K.
- Cumberland Pharmaceuticals Inc. other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for fiscal 2013 was -$46.80K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest 12 month |
|---|---|
| 2019-12-31 | -$8.75K 8-K · filed 2020-12-10 |
| 2018-12-31 | -$75.70K 8-K · filed 2020-12-10 |
| 2017-12-31 | -$71.18K 8-K · filed 2020-12-10 |
| 2016-12-31 | -$59.26K 10-K · filed 2019-03-12 |
| 2015-12-31 | -$60.24K 10-K · filed 2018-03-09 |
| 2014-12-31 | -$61.26K 10-K · filed 2017-03-13 |
| 2013-12-31 | -$46.80K 10-K · filed 2016-03-14 |
| 2012-12-31 | -$36.29K 10-K · filed 2015-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |